Tromantadine

This classification denotes an antiviral agent with the molecular formula C16H28N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H191JFG8WA, chemically known as 2-(2-(dimethylamino)ethoxy)-n-tricyclo(3.3.1.13,7)dec-1-ylacetamide but generally known as tromantadine, which bears US NIH Compound Identifier 64377. European Medicines Agency schedules Tromantadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11335MIG. The term TROMANTADINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules tromantadine in its Anatomical Therapeutic Chemical (ATC) Classification. TROMANTADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tromantadine under HS 29242995 and SITC 51479. As of Q4 2014, TROMANTADINE remains the US FDA Preferred Term for this commodity. Tromantadine bears US NLM identifiers UMLS ID C0077379 and NCI Concept Code C81608. SMILES: O=C(NC12CC3CC(C2)CC(C1)C3)COCCN(C)C.